Logo Image
|Articles|July 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-07-01-2001
  • Volume 0
  • Issue 0

Pharmacies: OTC Price Wars

Author(s)Kevin Gopal

London, United Kingdom-The UK OTC trade association supports the Community Pharmacy Action Group (CPAG) in its decision to withdraw a court case regarding the price-fixing of OTC drugs after the judge said there was little evidence that abolition of price maintenance would harm community pharmacists. The withdrawal brings an end to a long-running court battle pitting the pharmaceutical industry against an equally powerful corporate enemy, the supermarkets.

Articles in this issue

about 25 years ago

One Disease at a Time

about 25 years ago

Overview of the Industry: A World of Opportunities

about 25 years ago

The Power Shift

about 25 years ago

A Giant Stumbles

about 25 years ago

Overruled: No More Dual Pricing

about 25 years ago

Submerged

about 25 years ago

Generic Threat

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Fayuvi
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Read more
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Addressing MFN Innovation Concerns
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Read more